Leveraging Genpact's data, technology and AI
expertise to future-proof STADA's finance organization and drive
competitive advantages
NEW
YORK, Sept. 12, 2024 /PRNewswire/
-- Genpact (NYSE: G), a global professional services and
solutions firm delivering outcomes that shape the future, and
STADA (SAZ.DE), a leading manufacturer of consumer healthcare,
generic and specialty pharma medicines, today announced the renewal
of a multi-year partnership. The new chapter of innovation is aimed
at further derisking, scaling, and simplifying STADA's finance
operations to drive competitive advantages.
"Genpact has enabled us to handle
end-to-end tasks efficiently and cost-effectively," - Boris Döbler,
Group CFO, STADA.
"This renewal exemplifies our leadership in finance and
accounting services," said Sanjiv
Tandon, Global Business Unit Leader, Life Sciences and
Healthcare, Genpact. "By combining this expertise with our
digital leadership and industry knowledge, we will enhance STADA's
decision-making with actionable finance data, automate key F&A
processes, and support regulatory compliance – ultimately enabling
the company to continuously scale and excel in its industry."
Since 2019, Genpact's partnership with STADA has centered on
leveraging automation and process-harmonization to enhance critical
operations. Implementing technologies such as Genpact's Cora
APFlow has improved the accuracy of critical processes such as
accounts payable and receivable, streamlined data transparency, and
empowered STADA's teams to focus on strategic initiatives that
drive business outcomes.
"STADA's rapid growth and complex operations require a scalable
and efficient platform. Our partnership with Genpact has enabled us
to create automated processes that handle end-to-end tasks like
procure-to-pay and order-to-cash efficiently and cost-effectively,"
said Boris Döbler, Group Chief Financial Officer, STADA.
"This allows our internal teams to focus on high-value activities.
By leveraging data, analytics, and process automation, we're not
only reducing costs but also improving accuracy, quality, and
customer satisfaction."
Genpact has been instrumental in optimizing STADA's finance and
procurement processes, from supplier invoicing to financial
reporting, leveraging advanced technology and deep finance and
accounting expertise. Based on this strong foundation, the
companies also are partnering to implement and leverage tools and
technologies like S4HANA and generative AI.
For more information on Genpact's capabilities and services for
the life sciences and healthcare industries, visit here.
About Genpact
Genpact (NYSE: G) is a global
professional services and solutions firm delivering
outcomes that shape the future. Our 125,000+ people across 30+
countries are driven by our innate curiosity, entrepreneurial
agility, and desire to create lasting value for clients. Powered
by our purpose – the relentless pursuit of a world that works
better for people – we serve and transform leading
enterprises, including the Fortune Global 500, with our deep
business and industry knowledge, digital operations services,
and expertise in data, technology, and AI.
Get to know us at genpact.com and
on LinkedIn, X, YouTube,
and Facebook.
MEDIA CONTACT:
Sue
Martenson
Genpact Media Relations
+1
978-905-9582
susan.martenson@genpact.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/genpact-and-stada-renew-multi-year-partnership-to-enhance-finance-operations-302245419.html
SOURCE Genpact Ltd.